2nd Quarter - Report

NATIONAL ASSOCIATION OF CHAIN DRUG STORES for NATIONAL ASSOCIATION OF CHAIN DRUG STORES

Firm
Client
Income
—
Expenses
$400,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Animals ANI

H.R. 1607 Fairness to Pet Owners Act

LobbyistCovered position, as disclosed
STEVEN C ANDERSON —
VANESSA L CALLEN —
YVONNE HAMPEL —
AMBER MANKO —
KEVIN N NICHOLSON —
THOMAS ALFRED O'DONNELL —
WILLIAM TIGHE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1607 (116th)

Alcohol and Drug Abuse ALC

H.R. 1614 A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes S. 724 A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes

LobbyistCovered position, as disclosed
STEVEN C ANDERSON —
VANESSA L CALLEN New —
HEIDI ANN ECKER —
YVONNE HAMPEL —
AMBER MANKO —
KEVIN N NICHOLSON —
THOMAS ALFRED O'DONNELL —
WILLIAM TIGHE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 724 (116th), H.R. 1614 (116th)

Civil Rights/Civil Liberties CIV

H.R. 5 Equality Act of 2019 S. 788 Equality Act of 2019

LobbyistCovered position, as disclosed
STEVEN C ANDERSON —
VANESSA L CALLEN New —
HEIDI ANN ECKER —
YVONNE HAMPEL —
AMBER MANKO —
KEVIN N NICHOLSON —
THOMAS ALFRED O'DONNELL —
WILLIAM TIGHE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 788 (116th), H.R. 5 (116th)

Pharmacy PHA

H.R. 1614 A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes S. 724 A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes S.340 CREATES Act of 2019 H.R. 985 FAST Generics Act of 2019 S.640 Phair Pricing Act of 2019 S. 97 Affordable and Safe Prescription Drug Importation Act S. 61 Safe and Affordable Drugs from Canada Act of 2019 H.R. 1034 Phair Pricing Act of 2019 H.R. 965 CREATES Act of 2019 H.R. 1478 Affordable Insulin Act of 2019 H.R. 447 Affordable and Safe Prescription Drug Importation Act H.R. 1499 Protecting Consumer Access to Generic Drugs Act H.R. 3417 The Beneficiary Education Tools, Telehealth, and Extenders Re-authorization Act of 2019 H.R. 2296 Fair Accountability and Innovative Research Drug Pricing (FAIR Drug Pricing) Act of 2019 H.R. 1607 Fairness to Pet Owners Act H.R. 3379 Priced Relief, Innovation, and Competition for Essential Drugs (PRICED) Act H.R. 478 Safe and Affordable Drugs from Canada Act of 2019

LobbyistCovered position, as disclosed
STEVEN C ANDERSON —
VANESSA L CALLEN New —
HEIDI ANN ECKER —
YVONNE HAMPEL —
AMBER MANKO —
KEVIN N NICHOLSON —
THOMAS ALFRED O'DONNELL —
WILLIAM TIGHE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 724 (116th), S. 340 (116th), H.R. 3379 (116th), H.R. 1614 (116th), H.R. 965 (116th), S. 97 (116th), H.R. 1034 (116th), H.R. 2296 (116th), H.R. 478 (116th), H.R. 1607 (116th), H.R. 3417 (116th), H.R. 1478 (116th), H.R. 447 (116th), H.R. 985 (116th), S. 640 (116th), H.R. 1499 (116th), S. 61 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.